查詢結果分析
相關文獻
- 乳癌患者輔助性賀爾蒙治療簡介
- 第三代芳香環酶抑制劑停經婦女乳癌治療新希望
- 乳癌荷爾蒙治療中醫輔助療法
- The Effects of Pesticides Chlordane, Dieldrin and Endosulfan on the Growth of Human Breast Cancer Cell Lines MCF-7 and SK-BR-3
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
- Cystic Hypersecretory Intraductal Carcinoma of the Breast--Case Report
- Timing of Shoulder Exercise after Modified Radical Mastectomy: A Prospective Study
- 前哨淋巴掃描診斷乳癌早期轉移
- Measurement of the Quality of Life during Different Clinical Phases of Breast Cancer
- The Prognostic Significance of Pathologic Characteristics of Breast Cancer Patients in Taiwan
頁籤選單縮合
題名 | 乳癌患者輔助性賀爾蒙治療簡介=Adjunct Endocrine Therapy for Breast Cancer |
---|---|
作者 | 賴怡珊; 童玟津; | 書刊名 | 藥學雜誌 |
卷期 | 31:4=125 2015.12[民104.12] |
頁次 | 頁38-42 |
分類號 | 418.27 |
關鍵詞 | 輔助性賀爾蒙治療; 乳癌; 芳香環酶抑制劑; Tamoxifen; |
語文 | 中文(Chinese) |
中文摘要 | 乳癌患者的輔助性賀爾蒙治療包含了 tamoxifen、芳香環酶抑制劑及卵巢根除或抑 制,近期研究發現延長使用賀爾蒙治療可以持續改善乳癌的復發率及存活率,綜合分析 也發現對於停經後患者使用接續治療或轉換治療可以帶來更多的效益,因此賀爾蒙治療 的方式及療程非常多元,而選擇何種治療方式則是非常個人化的,此外,了解治療中可 能發生的副作用,並盡早給予處置來增加患者的順服性,亦是非常重要的課題。 |
英文摘要 | Adjunct endocrine therapy for breast cancer included tamoxifen, aromatase inhibitor and ovarian ablation or suppression. Recent studies demonstrated extended therapy consistently improves the recurrence of breast cancer and survival. Meta-analysis also showed the sequencing or switching therapy were more benefit for postmenopausal women. Therefore, the treatment approach was various and should be selected individualized. Besides, understanding the endocrine therapy induced-adverse effects and managing it early and rapidly to enhance patients' adherence were also very important. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。